Is NRTSF or MRK a better dividend investment in 2026?

NRTSF currently yields 200000000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: NRTSF offers higher current income.

What is the dividend yield difference between NRTSF and MRK?

NRTSF has a forward dividend yield of 200000000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 199999997.24 percentage points.

Home › Compare › NRTSF vs MRK

NRTSF vs MRK: Dividend Comparison 2026

NRTSF yields 200000000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NRTSF wins by $1.3558155772724413e+43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NRTSF

● Live price

200000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.3558155772724413e+43M

Annual income

$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00

Full NRTSF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — NRTSF vs MRK

📍 NRTSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NRTSF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NRTSF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NRTSF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRTSF

Annual income on $10K today (after 15% tax)

$17,000,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$11,512,836,890,545,420,000,000,000,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, NRTSF beats the other by $11,512,836,890,545,420,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRTSF + MRK for your $10,000?

NRTSF: 50%MRK: 50%

100% MRK50/50100% NRTSF

Portfolio after 10yr

$6.779077886362206e+42M

Annual income

$6,772,256,994,438,482,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.90%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NRTSF

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

0.9

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRTSF buys

MRK buys

No recent congressional trades found for NRTSF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNRTSFMRK

Forward yield	200000000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	32.7% ✓
Portfolio after 10y	$1.3558155772724413e+43M	$56.8K ✓
Annual income after 10y	$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$1.3557262927128971e+43M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: NRTSF vs MRK ($10,000, DRIP)

Year	NRTSF Portfolio	NRTSF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$10,000,010,700	$10,000,000,000.00	$11,206	$366.19	+$10000.00M → NRTSF
2	$4,672,912,896,273,132	$4,672,902,196,261,683.00	$12,650	$502.35	+$4672912896.26M → NRTSF
3	$1,020,380,774,379,872,600,000	$1,020,375,774,363,073,600,000.00	$14,407	$694.19	+$1020380774379872.63M → NRTSF
4	$104,117,924,275,745,270,000,000,000	$104,116,832,468,316,660,000,000,000.00	$16,585	$967.82	+$104117924275745259520.00M → NRTSF
5	$4,964,553,026,072,278,600,000,000,000,000	$4,964,441,619,893,303,400,000,000,000,000.00	$19,342	$1,363.89	+$4.964553026072278e+24M → NRTSF
6	$110,619,615,037,467,830,000,000,000,000,000,000	$110,614,302,965,729,920,000,000,000,000,000,000.00	$22,913	$1,947.19	+$1.1061961503746783e+29M → NRTSF
7	$1,151,845,242,391,102,900,000,000,000,000,000,000,000	$1,151,726,879,403,013,000,000,000,000,000,000,000,000.00	$27,662	$2,823.89	+$1.151845242391103e+33M → NRTSF
8	$5,605,227,219,644,151,000,000,000,000,000,000,000,000,000	$5,603,994,745,234,793,000,000,000,000,000,000,000,000,000.00	$34,159	$4,173.35	+$5.605227219644151e+36M → NRTSF
9	$12,749,330,698,549,516,000,000,000,000,000,000,000,000,000,000	$12,743,333,105,424,497,000,000,000,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$1.2749330698549515e+40M → NRTSF
10	$13,558,155,772,724,413,000,000,000,000,000,000,000,000,000,000,000	$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$1.3558155772724413e+43M → NRTSF

NRTSF vs MRK: Complete Analysis 2026

NRTSF — Stock

Nobilis Health Corp. engages in the operation and development of outpatient surgery centers. The firm owns and manages ambulatory and acute care facilities to deliver innovative surgical services. It operates through Medical Services and Marketing Services segment. The Medical Services segment provides the operation of hospitals, outpatient facilities, and other various related health care services. The Marketing Services segment provides marketing services, patient education services, and patient care coordination management services. The company was founded on March 16, 2007 and is headquartered in Houston, TX.

Full NRTSF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this NRTSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRTSF vs SCHD NRTSF vs JEPI NRTSF vs O NRTSF vs KO NRTSF vs MAIN NRTSF vs JNJ NRTSF vs ABBV NRTSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.